We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
TUWOY's Merger Plans Ditched by Capricorn for Israel's NewMed
Read MoreHide Full Article
The British oil and gas exploration and development company — Capricorn Energy — has abandoned its merger plans with Tullow Oil Plc (TUWOY - Free Report) in favor of a deal with the Israeli natural gas group NewMed Energy.
The all-stock deal between Capricorn and NewMed will lead to the creation of an Israel-Egypt-focused gas producer. This will include NewMed's interest in Israel's giant Leviathan offshore field at a time when Europe is hustling for non-Russian energy supplies.
Per the deal, NewMed shareholders will get 2.337344 new Capricorn shares for each of their existing units. Capricorn shareholders will hold about 10.3% of the combined entity with NewMed stockholders, along with the partnership’s current general partner owning the remaining interest.
Additionally, Capricorn shareholders will also receive a cash special dividend of around $620 million before the business combination.
This announcement comes weeks after Tullow stated that it was “fully committed” to the earlier declared all-stock deal with Capricorn. The deal would have led to the formation of a £1.4 billion Africa-focused energy company despite Capricorn looking for alternatives following shareholders’ opposition to its merger with Tullow.
The Capricorn-NewMed merger is anticipated to be wound up in the first quarter of 2023, subject to shareholders’ approval from both firms.
The U.K.-based, West Africa-focused Tullow Oil operates as an independent oil and gas exploration and production company in Europe. The company has a large portfolio of exploration and production assets, with a focus on balanced long-term growth. It is headquartered in London, the United Kingdom.
The Zacks Consensus Estimate for HF Sinclair’s 2022 earnings has been revised about 18.1% upward over the past 60 days from $12.07 per share to $14.26.
The consensus estimate for DINO’s 2022 earnings is pegged at $14.26 per share, up 838.2% from the year-ago earnings of $1.52.
The Zacks Consensus Estimate for Earthstone’s 2022 earnings is pegged at $5.85 per share, indicating an increase of about 368% from the year-ago earnings of $1.25.
ESTE beat the Zacks Consensus Estimate for earnings in all the trailing four quarters, the average being around 27%.
The Zacks Consensus Estimate for Murphy USA’s 2022 EPS has been revised upward by about 14% over the past 60 days from $21.39 to $24.38.
MUSA beat the Zacks Consensus Estimate for earnings in all the trailing four quarters, the average being 49%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
TUWOY's Merger Plans Ditched by Capricorn for Israel's NewMed
The British oil and gas exploration and development company — Capricorn Energy — has abandoned its merger plans with Tullow Oil Plc (TUWOY - Free Report) in favor of a deal with the Israeli natural gas group NewMed Energy.
The all-stock deal between Capricorn and NewMed will lead to the creation of an Israel-Egypt-focused gas producer. This will include NewMed's interest in Israel's giant Leviathan offshore field at a time when Europe is hustling for non-Russian energy supplies.
Per the deal, NewMed shareholders will get 2.337344 new Capricorn shares for each of their existing units. Capricorn shareholders will hold about 10.3% of the combined entity with NewMed stockholders, along with the partnership’s current general partner owning the remaining interest.
Additionally, Capricorn shareholders will also receive a cash special dividend of around $620 million before the business combination.
This announcement comes weeks after Tullow stated that it was “fully committed” to the earlier declared all-stock deal with Capricorn. The deal would have led to the formation of a £1.4 billion Africa-focused energy company despite Capricorn looking for alternatives following shareholders’ opposition to its merger with Tullow.
The Capricorn-NewMed merger is anticipated to be wound up in the first quarter of 2023, subject to shareholders’ approval from both firms.
The U.K.-based, West Africa-focused Tullow Oil operates as an independent oil and gas exploration and production company in Europe. The company has a large portfolio of exploration and production assets, with a focus on balanced long-term growth. It is headquartered in London, the United Kingdom.
Tullow currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks from the energy space that warrant a look include HF Sinclair (DINO - Free Report) , Earthstone Energy and Murphy USA (MUSA - Free Report) , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for HF Sinclair’s 2022 earnings has been revised about 18.1% upward over the past 60 days from $12.07 per share to $14.26.
The consensus estimate for DINO’s 2022 earnings is pegged at $14.26 per share, up 838.2% from the year-ago earnings of $1.52.
The Zacks Consensus Estimate for Earthstone’s 2022 earnings is pegged at $5.85 per share, indicating an increase of about 368% from the year-ago earnings of $1.25.
ESTE beat the Zacks Consensus Estimate for earnings in all the trailing four quarters, the average being around 27%.
The Zacks Consensus Estimate for Murphy USA’s 2022 EPS has been revised upward by about 14% over the past 60 days from $21.39 to $24.38.
MUSA beat the Zacks Consensus Estimate for earnings in all the trailing four quarters, the average being 49%.